Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HBV-IN19 TFA inhibits the secretion and/or production of HBsAg and has an inhibitory effect on hepatitis B virus (HBV) infection and can be used in studies of HBV infection, including chronic HBV infection.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 491,500 |
50 mg | 約10-14 週間 | ¥ 639,500 |
100 mg | 約10-14 週間 | ¥ 808,000 |
説明 | HBV-IN19 TFA inhibits the secretion and/or production of HBsAg and has an inhibitory effect on hepatitis B virus (HBV) infection and can be used in studies of HBV infection, including chronic HBV infection. |
分子量 | 556.535 |
分子式 | C26H31F3N2O8 |
CAS No. | 2241575-60-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HBV-IN-19 TFA 2241575-60-8 Inhibitor inhibitor inhibit